| AVIVA INVESTORS - GLOBAL EMERGING MARKETS CORE B EUR | RVI EMERGENTES | 48,06% | 56,02% | 29,54% | 69,37% |
| BNP PARIBAS DISRUPTIVE TECHNOLOGY PRIVILEGE CAP | TMT | 48,06% | 76,99% | 88,00% | 489,74% |
| GOLDMAN SACHS US SMALL CAP CORE EQUITY PORTFOLIO R (SNAP) USD DIS | RVI USA SMALL/MID CAP | 48,06% | 63,32% | 54,44% | 182,31% |
| PRIVILEDGE - ALPHA JAPAN (EUR) N CAP SYST. HDG | RVI JAPÓN | 48,06% | 114,04% | 124,65% | 295,70% |
| JPM EMERGING MARKETS DIVIDEND C (ACC) USD | RVI EMERGENTES | 48,05% | 58,98% | 54,75% | 163,09% |
| JPM THEMATICS-GENETIC THERAPIES A (DIST) EUR (HEDGED) | BIOTECNOLOGÍA | 48,05% | 7,11% | -31,49% | · |
| ROBECO SUSTAINABLE ASIAN STARS EQUITIES S USD | RVI ASIA EX-JAPÓN | 48,05% | 54,64% | 39,60% | · |
| GAM MULTISTOCK EMERGING MARKETS EQUITY E EUR | RVI EMERGENTES | 48,03% | 51,55% | 16,37% | 91,64% |
| GOLDMAN SACHS US SMALL CAP CORE EQUITY PORTFOLIO E (CLOSE) EUR CAP | RVI USA SMALL/MID CAP | 48,03% | 59,26% | 49,10% | 161,45% |
| SPDR MSCI EUROPE TECHNOLOGY UCITS ETF | TMT | 48,02% | 63,62% | 60,51% | 258,23% |
